chrisvoncsefalvay/vaers-outcomes huggingface dataset:
7/23/21: patient came to ED with increased confusion, shakiness, and generally feeling unwell the past day. husband diagnosed with COVID-19 day prior. Patient tested positive for COVID-19. diagnosed with UTI, shortness of breath/cough/hypoxia.  Note: patient previously vaccinated with COVID-19 Pfizer vaccine on: 4/10/2021, 5/2/2021 7/27/21: patient still admitted at the time of this report submission.
Patient checked out - went to car with mother. Came back into office about 5 minutes later with c/o chest pain. Provider examined child and could find no basis for chest pain and no relationship to vaccine administration. MOC reports that chest pain continued with exacerbation along with rash and redness face and ears that prompted a visit to an ER later in the day. ER visit reports no sign of rash or redness but Dx: "possible Rxn to vaccine". ER reports also no basis for chest pain and Dx: chest pain; probably not related to vaccine administration.
Tinnitus in one ear at a time, but affecting both ears. Intermittent Vertigo. Small slightly raised red spots that are not itchy, located under arm pits, and on neck. Black spots in vision that come and go.
Patient developed symptoms early the next morning after the Covid vaccine. Started with fever 102.8 and body aches. had fever for 5 days. Extreme low energy for 8 days and continuing. Headaches everyday. cough for the last 2 days. no SOB, no N/V D, no Sore throat,  no nasal congestion. no loss of taste and smell.  not pregnant.
Vaccine recipient received a Pfizer vaccine injection for the first dose in the COVID 19 vaccination 2 dose series.   The recipient received the Moderna brand vaccine for the second dose in the 2 dose series.  Recipient was monitored for 30 minutes post vaccination with no reported signs/symptoms of reaction.
That afternoon I received the shot I had pain all down my arm and in my shoulder front and back and neck and into my left chest area. As the night went on the pain was so intense and hurting in my left arm I had a very hard time sleeping.  Have progressed to 16 disability in my left hand arm now. Have twitching of my left arm constantly now.
Rosacea flare up in the left eye; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) in the right arm on 05Mar2021 at 10:30 (at the age of 59-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) in the right arm on 26Mar2021 at 10:30 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history included rosacea and thyroid disorder. The patient previously had taken epinephrine and experienced drug allergy. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), metronidazole cream (MANUFACTURER UNKNOWN) and azelaic acid (AZELEX) all from an unknown date for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced rosacea flare up in the left eye a couple of days after first vaccine on 08Mar2021. The patient figured it was coincidence.  Second flare up after second vaccine was on the next day. The patient did not receive any treatment for the event. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event rosacea flare up in the left eye was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
I began experiencing extreme dizziness and brain fog. Because of these symptoms I ended up in the emergency room twice.
Around 5 am the night after receiving the shot, I woke up extremely nauseous. I did not have diarrhea or vomiting, and eventually the nausea was so great that I had some kind of fainting episode where I hit my head and started knocking things over. I went to urgent care and the ER the next day to make sure I did not have a concussion.
Story told by mom 12-3-07.  In health department 10-18-07 8:30 for well check & shots.  Mom states had seizure in car at 5:30pm.  Mom driving, mom present-stiff, drooling, unresponsive x15 mins per mom.  Ambulance called & patient woke up with them present.  Taken to ER.  Mom states no fever at ER/no tx.  To Dr. 10-19-07, child had 2 previous seizures, both on same day 7-17-07 per mom, had 103 degree fever per mom.  No tx. by Dr. 10-19-07 per mom.
10x14 cm red patch w/centrol clearing around immun on rt thigh (vastus); no evidence of cellulitis started 6 or 7 hr p/inject w/heat & redness;
Pt stated itchy, raised red rash began morning of 10/27/13 (6 days post vaccination) on back, spread to trunk & down both legs.  Pt took oral Benadryl with no relief, sought care at Urgent Care Center morning of 10/27/13 and was started on oral prednisone.  Spoke with pt by phone 10/29/13 and states itching improved & rash is resolving with medication.
While using Vanish point needle and syringe, needle retracted while giving injection. Pt was unable to receive full dose of 2nd covid vaccine. per doctor, additional vaccine was given for full immunization.
12 hours after vaccination began experiencing fever, chills, body aches, slight head ache - lasted around 12 hours Had slight pain above eye prior to getting vaccination Saw PCP on 01/08/2021 due to eye pain - had CT scan for possible aneurysm, found 2 spots on brain, thought patient had shingles On 01/10/2021 shingles rash appeared
I saw the patient on 12/10/21 with complaints of muscle aches, as well as a vaginal ulcer. She received her COVID vaccines on 11/12/21, then 12/4/21. Mom reported that after her first vaccine, she had muscle aches in her forearms, shins, and feet - Mom was vague on the exact date this started.  This resolved, then after her 2nd COVID vaccine, she again had muscle aches.  On 12/8/21 she had trouble walking and arm pain. Also, she also had a vaginal ulcer that appeared around 12/1/21. Of note, Mom reported that everyone in the house had a URI around 11/19/21. Her exam on 12/10/21 was normal, aside from the vaginal ulcer.  When I called Mom to discuss the labs on 12/14/21, pt.'s muscle pain and vaginal ulcer had resolved. I suspect she had myositis, but it's not clear if that was due to the vaccine or the URI that Mom reported. It's not clear if the vaginal ulcer is related to the myalgias or not.
Received 2/2 COVID-19 vaccine 1/26/21 near 8:30 am. Shortly before 5 am the next morning (1/27) employee woke up & noticed tongue hurt, then discovered left unilateral tongue swelling and  was having difficulty speaking clearly. Employee was unable to find Benedryl at home & tongue was continuing to swell  and was having some difficulty swallowing so proceeded to ED. Employee also had 3 additional episodes of angioedema - 1st right upper and lower lip, 2nd left upper lip and 3rd right outer foot near heal and developed a 1/2 gumball size lump. Additional episodes occurred within 10 days after receiving the vaccination and all resolved with use of benadryl po and resolved within 24 hours.
about a week after getting the second dose of the covid vax he developed a severe case of rheumatoid arthritis.  His neck became stiff, his hands became hot and swollen.  All of the joints were inflamed including his hips, knees, feet and all parts of his body that came on all at once.  He states it was so dramatic he had problems getting up and down and moving around.  He saw his PCP, in April.  He was prescribed prednisone.  He was instructed to take naproxen sodium after finishing the steroids. He has improved about 90% at this time.  His doctor says if his symptoms do not improve then will do blood work and refer him to a Rheumatologist.
Left deltoid region is red, swollen, painful. Sx started 9-22-05 at 9:30 am. Afebrile. Seen M.D. 9-23 at 11am.  Dx: localized reaction from DTAP immunization. Treatment:  Cold packs and motrin prn.  Follow up if no improvement in 24 hours.
patient received flublock (has a history of using fluzone). about an hour later patient returned to the pharmacy complaining of extreme itchiness. She stated on a scale of 1-10 that is was over a 10. Visual inspection showed some redness but hard to tell if caused by rubbing. No swelling noted. Patient stated that she was not experiencing any swelling or difficulty breathing.  An ice pack was applied and the patient stated after about 10 minutes the itching was down to a 4. She was offered diphenhydramine but declined due to the fact she was driving. She stated she had allegra at home and would take that when she got home. We discussed anaphylaxis symptoms and what to do. After 15 minutes patient was feeling better and wanted to go home. She was advised to reach out the us if any further concerns. I did leave a message at her provider's office mentioning what had occurred and asking for a call back to confirm they had received the message.
A report was received from a healthcare professional on 05 Dec 2006, concerning a 44 year old vaccinee (sex unspecified). No details concerning the vaccinee's past medical history or concomitant medications were provided. The vaccinee was administered Fluvirin 0.5ml by intramuscular injection on an unspecified date, the vaccinee then developed arm pain, and was subsequently diagnosed as having brachial neuritis. The reporter considered the event to be serious, hospitalisation and disability/incapacity. The events are ongoing. Further information is requested.
11year old patient was administered incorrect dose of 0.3 ml of Pfizer Bivalent 12+. MD spoke with parent and will follow up with her in 24 hours. MD went over possible side effect and allergic reaction symptoms to look out for.
When I first received my vaccine I got a headache and I started to feel really stuffy and it lasted for 1 week straight. I then felt pain in my arm and it hurts terribly when I move it.
Pt recvd 3 Hep B vax doses on 26JUL89, 29AUG89, 25JAN90 following these titer=6;
This spontaneous report has been received from a nurse practitioner regarding a patient of unknown age or gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated VARIVAX dose 1, (dose, lot # and expiry date unknown). On 12-MAR-2010, patient received improperly stored VARIVAX dose 2, from lot # 665413/1128Y expiry date: 07-AUG-2011. No adverse effects were reported. The reporter stated that inconsistencies in storage temperature was identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provide 100 percent assurance on vaccine stability. This is one of the several reports received from the same reporter. Additional information has been requested.
Caller reporting temperature excursion, product was administered; This spontaneous report was received from a registered nurse referring to a 14-year-old patient. The patient's pertinent concurrent conditions, medical history and concomitant medications were not reported.    On 15-DEC-2020, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (lot number 1637641 and expiration date reported 16-FEB-2022) and hepatitis a vaccine, inactivated (VAQTA) (lot number T013204 and reported expiration date 03-DEC-2021) both as prophylaxis at a dose of 0.5 milliliter, concentrations, vaccination scheme frequency, routes of administration and anatomical locations were not reported.  According to the reporter, the temperature excursion of both vaccines was 0.38 degrees Celsius for a time frame of four hours and 45 minutes and 11.09 degrees Celsius for 1 hour and 30 minutes on an unspecified date (product storage error), hepatitis a vaccine, inactivated (VAQTA) without any previous temperature excursion, however the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) vaccine had a previous temperature of excursion of 17.52 degrees Celsius for 2 hours and 42 minutes; which were detected by a digital data logger.
Pneumonia; Fevers; This is a spontaneous report from a contactable consumer (patient). A patient of an unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiration date were not reported), via an unspecified route of administration in 2021 as dose 3 (booster), single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number and expiration date were not reported), via an unspecified route of administration, on an unspecified date as dose 1, single and dose 2, single for COVID-19 immunization. After fevers for 6 days in 2021, the patient went into the emergency room (ER). They found out the patient had pneumonia. The patient believed that this was caused by the vaccine. The outcome of the events was unknown at the time of report.  The lot number for BNT162B2 was not provided and will be requested during follow up.
Runny nose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (Runny nose) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The medical history was not provided by the reporter. .  Concomitant products included QUETIAPINE FUMARATE for an unknown indication.    On 03-Feb-2021 at 7:49 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced RHINORRHOEA (Runny nose). The patient was treated with VITAMIN C [ASCORBIC ACID] on 05-Feb-2021 for Runny nose, at an unspecified dose and frequency. At the time of the report, RHINORRHOEA (Runny nose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported that the event runny nose lasted for 1.5 days. Patient reported no events after second dose. Patient received second dose in Mar 2021 and did not experience any adverse event.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow up document received on 12 Jul 2021, duration of event headache and second dose information updated.
sudden onset of behavioral changes & gen coarse tremors;CT scan/Blood & CSF cult for bacterial infect negative;
Numbness in Left side of face.  Started after I left the facility and continues to be present a week later. No drooping of face.  It just feels like my face is waking up after dental work.
suspected vaccination failure; still got it; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient had reported for him/herself. The age at vaccination was not reported. The patient received Shingles vaccine quite a few years ago from the date of reporting. After receiving Shingles vaccine, the patient still got shingles recently and probably the worst and longest episode yet till the time of reporting. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
pt recv vax 5NOV97 & exp wheezing;MD felt that wheezing was not r/t therapy w/vax;
Doses given after temperature excursion; Product storage error; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Doses given after temperature excursion) and PRODUCT STORAGE ERROR (Product storage error) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.
Head ache, nausea, weakness to the point of near helplessness,. I couldn?t eat & just slept for approximately one day/night & into second day.
Pregnant; Vaccine was given to 16 years of age patient; A report was received from a nurse concerning a 16-year-old, female patient who was participating in the mRNA-1273program and the patient received the vaccine at inappropriate age and while pregnant.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 08 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number 027L20A) intramuscularly in the right deltoid for prophylaxis of COVID-19 infection.   The reporter called and stated that their office had given the first dose of Moderna vaccine to a 16 year old girl who was pregnant. The patient's due date is April 2021. No treatment information was provided.   Action taken with mRNA-1273 in response to the events was not reported.   The events, vaccine exposure to patient of inappropriate age while pregnant, were considered resolved.; Reporter's Comments: This spontaneous  case concerns a 16-year-old female who received the vaccine at inappropriate age (inappropriate age at vaccine administration) and while pregnant for mRNA-1273 (Lot number 027L20A, expiration date unknown). No medical history, obstetric or gynecological history was provided.  Estimated date of delivery is April 2010. There were no reported AEs associated with the event of inappropriate age at vaccine administration.
Waited for 15 minutes after the 15 minutes and felt fine. Left and approximately 25 minutes after leaving, patient started to have tightness all down her left side of her body (chest, jaw, face and throat). Took 50mg of Benadryl and waited in the ER parking lot for 1 hour until she felt okay to go home. Patient was still having tightness in her chest when seen on 3/16 with a slight wheeze (non-asthmatic). Felt very winded x3 days. Dr. recommended not getting 2nd dose and consider booster of J & J vaccine when available.
Fatigue and Fever late and by midnight cold chills, headache, nausea. 102.6F fever over night and broke the next day. By midday only headache and slight fever. Stabbing pain and no strength in left arm until next day.
weakness in the right arm; vertigo; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness in the right arm) and VERTIGO (vertigo) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness in the right arm) and VERTIGO (vertigo). At the time of the report, ASTHENIA (weakness in the right arm) outcome was unknown and VERTIGO (vertigo) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-064977 (E2B Linked Report).; Sender's Comments:  MOD21-064977:
Soreness in his arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in his arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (Soreness in his arm). At the time of the report, PAIN IN EXTREMITY (Soreness in his arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
I thought I had a sore throat. I woke up from a nap in the afternoon with a fever. I had low fever, a headache and fatigue. The symptoms lasted for one day. I treated the symptoms with ibuprofen and within 24 hours I was recovered. I did not receive any treatment. I completely recovered.
Clammy skin, difficulty swallowing, numbness and itching.  Rash all around body.  Treated with 50mg Benadryl PO at 4:15 PM.  Prescription for additional Benadryl given by provider.
Extreme exhaustion, day of injection then next day still exhausted plus slight fever 99. Lasted  about 30 hours.
Felt as if needle was still inside of arm, arm felt heavy, light headed, dizziness, sore, warm , muscle in arm hurt, looked like a big mosquito bight, swollen, itchy
This case meets vaccine breakthrough criteria review.  Patient presented to ED for evaluation of numbness and weakness, stroke work-up.  Denies COVID SxS
Computer was down so paper documentation was used.  On review of the paper documentation for entry into the computer when it was back up and working, it was noted that the lot number for the vaccine administered was for Flublok and not Flulaval.  There was no adverse effect noted at the time of vaccination A message was left for the patient's mother.
low grade fever (101), body aches, headache.  Lasted from about 8:30pm til bedtime.  Felt better next day
The patient let us know that when she had the vaccine in July, she experienced redness at the injection site starting about a week after the vaccine and it has lasted 6 weeks. The redness is in the central deltoid area where she had the shot, and she has not experienced any pain. She saw her physician who examined the area, and he prescribed Hydrocortisone cream.
mild case of the shingles on right side of stomach area approx. 6 inches by 4 inches tender to the touch t-shirt hurts the area
Fever, severe aches and pains still continued into the second day now. Chest pain along with major joint pain
Painful joints with the pain centering in my right knee.  Constant, needing assistance to walk at times, wakes me up at night with pain
No additional AE reported; Patient was administered expired PNEUMOVAX 23 via PNEUMOVAX 23 Prefilled Syringe on 11/07/2022; This spontaneous report was received from medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported.  On 07-NOV-2022, the patient was vaccinated with expired pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) injection, lot #U010534, expiration date: 31-OCT-2022, administered for prophylaxis (strength, dosing schedule, and route of administration were not provided) (expired product administered). No additional adverse event was reported (no adverse event).